soul trial oral semaglutide cardiovascular outcomes soul trial results SOUL: Bests Usual Care in High-Risk Type 2 Diabetes soul trial oral semaglutide cardiovascular
Description
Individual genetics, hydration status, and dose-escalation speed influence whether you'll develop this side effect
Weve lived it
2020;125 doi: 10.1016/j.peptides.2019.170201
Are side effects manageable
In a pooled analysis of glycemic control trials with oral semaglutide, diabetic retinopathy complications occurred in 4.2% of T2DM patients receiving semaglutide and 3.8% with comparator
Very high risk CKD vs
